Skip to main content

Bayer Seeks To Reverse $86M Roundup Verdict

Bayer Seeks To Reverse $86M Roundup Verdict

Bayer Seeks To Reverse $86M Roundup Verdict

Introduction

Attorney general for Bayer has asked the California appeals court to reverse an $86 million verdict, in which the company was held responsible for a couple's cancer caused by the glyphosate present in its weedkiller Roundup.

The lawsuit involves a couple who sprayed Roundup on their property for more than three decades to destroy weeds. A Californian jury awarded the couple $2 billion after finding glyphosate as the cause of cancer.

According to the Friday night filing with the California First District Court of Appeals in San Francisco, the company claimed that the verdict does not settle with the law nor with sound science.

Bayer has also appealed two other verdicts, and it is yet not clear when courts will issue rulings in those cases.

Six scheduled jury trials have been postponed in recent months, and Kenneth R. Feinberg, who is playing a mediator, has asked the court to postpone all the legal deadlines by one month for settlement talks.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!